Invention Grant
- Patent Title: Crystalline forms of an alkoxyimidazol-1-ylmethyl biphenyl carboxylic acid
-
Application No.: US14317060Application Date: 2014-06-27
-
Publication No.: US09249105B2Publication Date: 2016-02-02
- Inventor: Paul R. Fatheree , Venkat R. Thalladi
- Applicant: Paul R. Fatheree , Venkat R. Thalladi
- Applicant Address: US CA South San Francisco
- Assignee: Theravance Biopharma R&D IP, LLC
- Current Assignee: Theravance Biopharma R&D IP, LLC
- Current Assignee Address: US CA South San Francisco
- Agent Jeffrey A. Hagenah
- Main IPC: A61K31/4166
- IPC: A61K31/4166 ; C07D233/66 ; C07D233/70 ; A61K31/4164 ; A61K45/06
Abstract:
The invention provides crystalline salt forms of 4′-{2-ethoxy-4-ethyl-5-[((S)-2-mercapto-4-methylpentanoylamino)methyl]-imidazol-1-ylmethyl}-3′-fluorobiphenyl-2-carboxylic acid. This invention also provides pharmaceutical compositions comprising the crystalline compounds, processes and intermediates for preparing the crystalline compounds, and methods of using the crystalline compounds to treat diseases such as hypertension.
Public/Granted literature
- US20150133518A1 CRYSTALLINE FORMS OF AN ALKOXYIMIDAZOL-1-YLMETHYL BIPHENYL CARBOXYLIC ACID Public/Granted day:2015-05-14
Information query
IPC分类:
